Skip to content

To see the Combined effect of Panchakola siddha pana, Yusha, Valuka Swedana, Kostha Shuddhi with Eranda taila and Erandamooladi Yoga Basti followed by Amrita Ghrita Brumhana Snehapana treating Amavata.

A Clinical Study to Evaluate the Effect of Valuka Swedana, Erandamooladi Yoga Basti followed by Amrita Ghrita Bruhmana Snehapana in the Management of Amavata (Rheumatoid Arthritis).

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/048798
Enrollment
31
Registered
2023-01-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 20 yrs to 60 yrs. 2. Chronicity: 3. Gender: Both 4. Socio-economic status: All 5. Presence of minimum three clinical features of Amavata (Sandhishoola, Sandhishotha, Sandhistabdhata) & RA (both seropositive and seronegative) 6. The subjects who will fullfill the ACR-EULAR Criteria:2010 (presence of total score >= 6 from criteria) 7. Patient with history of undergone Panchakarma will also be included, after minimum period of washout one month.

Exclusion criteria

Exclusion criteria: 1. Juvenile R.A. 2. Chronicity > 5 years 3. Pulmonary tuberculosis, Hypertension, pregnant women. 4. Patient unfit for Swedana & Basti.

Design outcomes

Primary

MeasureTime frame
Reduction in Pain and Stiffness.Timepoint: (Day-0) (Day-17) (Day-32) (Day- 62)

Secondary

MeasureTime frame
1. Reduction in symptoms like Angamarda, Aruchi, Aalasya, Gaurava. 2. Improvement in overall Quality of Life.Timepoint: (Day-0) (Day-17) (Day-32) (Day- 62)

Countries

India

Contacts

Public ContactDr Prasanth Dharmarajan

All India Institute of Ayurveda

santoshbhatted@rediffmail.com9414048459

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026